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Hypertrophic Cardiomyopathy With Extreme Increase in Left
Ventricular Wall Thickness: Functional and Morphologic Features and
Clinical Significance
ERIC K. LOUIE, MD, FACC,* BARRY J. MARON, MD, FACCt
Bethesda. Maryland
Clinical and morphologic features of 34 patients with
hypertrophic cardiomyopathy and particularly marked
left ventricular hypertrophy were analyzed. Only pa-
tients with a ventricular septal thickness of at least 35
mm (range to 52 mm) were selected for the study; 31
(90%) had a diffuse pattern of hypertrophy also involv-
ing substantial portions of the left ventricular free wall.
Despite similar left ventricular morphology, these pa-
tients exhibited a broad spectrum of clinical findings and
natural history. Ten patients (29%) had hemodynamic
or echocardiographic evidence of basal subaortic ob-
struction (average gradient, 63 mm Hg); however, the
majority (24 [71%]) had no evidence of obstruction at
rest, despite substantial hypertrophy of the basal ante-
rior portions of septum and free wall. Although the elec-
trocardiograms of most patients (76%) showed patterns
of left ventricular hypertrophy, the magnitude of pre-
cordial QRS complexes was not markedly increased
(8 wave in lead VI or Vz, 27 ± 15 mm; R wave in lead
v, or V" 21 ± 9 mm).
The clinical course was variable in 30 patients who
were followed up for at least 1 year (mean 6 years).
Hypertrophic cardiomyopathy is characterized by an unex-
plained increase in left ventricular mass in the absence of
ventricular dilation (l). The magnitude and distribution of
left ventricular hypertrophy constitute a broad spectrum which
includes patients with marked and diffuse involvement of
the left ventricle as well as those with only modest or rel-
atively localized wall thickening (2-4).
Patients with hypertrophic cardiomyopathy also dem-
onstrate great variability in their clinical findings and natural
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Although no patient died, nine (30%) have exhibited
clinical deterioration, including two who spontaneously
developed complete heart block and one who collapsed
with ventricular fibrillation but survived. However, the
clinical condition of the majority of patients (21 [70%])
remained unchanged or improved. At the most recent
evaluation, 20 (67%) of the 30 patients were asympto-
matic or only mildly symptomatic, including 7 who re-
mained without symptoms throughout the period of fol-
low-up.
The subset of patients described in this report shows
the most striking morphologic alterations that occur in
hypertrophic cardiomyopathy and the most substantial
wall thickness of any cardiac disease. Although such
extreme increases in left ventricular mass might intui-
tivelysuggest a unique clinical expression and course for
these patients, the patients nevertheless demonstrated a
variety of clinical manifestations; their natural history
did not reflecta uniformly poor prognosis over the period
of follow-up, and two-thirds of the patients had only
mild or no symptoms at the most recent evaluation.
(J Am Coli Cardiol 1986;8:57-65)
history (5-14). Some patients die suddenly and prematurely
(often as the initial manifestation of their disease) (9,1 1-14),
whereas others may live relatively normal lives without
significant functional limitation (5,6,15). The determinants
of prognosi s in patients with hypertrophic cardiomyopathy
are not well defined , although it has been suggested that
particularly excessive left ventricular hypertrophy may have
some prognostic significance (12- 14).
We have observed a number of patients with hypertrophic
cardiomyopathy who had a particularly striking increa se in
left ventricular mass. In these patients, the massive myo-
cardial hypertrophy far exceeded that observed in most other
patients with hypertrophic cardiomyopathy , as well as in
patients with other cardiovascular diseases associated with
left ventricular hypertrophy (16-20) . We have analyzed in
detail the clinical and morphologic features in a group of
34 such patients to assess whether such a massive degree
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of left ventricular hypertrophy has a clearly adverse influ-
ence on the clinical findings and the natural history of their
disease.
Methods
Selection of patients. The case records of the Echo-
cardiography Laboratory of the Cardiology Branch at the
National Heart, Lung, and Blood Institute were reviewed
for the 6 year period from January 1979 through December
1984. During that time, 720 patients with hypertrophic car-
diomyopathy were assessed with both M-mode and two-
dimensional echocardiography and 34 (5%) met the follow-
ing criteria for inclusion in the study: 1) maximal thickness
of 35 mm or more in at least one area of the left ventricular
wall as identified with M-mode or two-dimensional echo-
cardiography; 2) absence of associated cardiovascular dis-
ease known to produce left ventricular hypertrophy, such
as aortic valve stenosis or systemic hypertension; and 3)
M-mode and two-dimensional echocardiograms of sufficient
technical quality to permit accurate assessment of left ven-
tricular wall thickness.
The 34 study patients' ranged in age (at most recent fol-
low-up evaluation) fro~ 10 to 50 years (mean 24); 15 were
younger than 20 years and 5 were older than 35 years.
Twenty-four were male and 10 were female.
Thirty-two of the 34 study patients were referred to our
institution with the diagnosis of hypertrophic cardio-
myopathy for the purpose of further evaluation and man-
agement (3 months to 10 years after initial identification of
their disease). The remaining two patients were referred for
evaluation solely because a family member was known to
have hypertrophic cardiomyopathy.
M-mode echocardiography. M-mode echocardiograms
were performed using a 2.25 MHz, 1.25 em diameter un-
focused Aerotech transducer and a Hoffrel 201 ultrasound
receiver interfaced with a Honeywell 1856 strip-chart re-
corder or an Irex System II ultrasound unit equipped with
a 2.25 MHz, 1.3 em diameter transducer. The methods for
imaging the ventricular septum and posterior left ventricular
free wall have been described previously (21,22). Ventric-
ular septal thickness was measured at the onset of the R
wave of the electrocardiogram at the level of maximal thick-
ness; thickness of the posterior free wall was measured
during the same phase of the cardiac cycle and at the same
level. Other cardiac dimensions were assessed according to
the criteria of the American Society of Echocardiography
(22). In selected instances cardiac dimensions were com-
pared with normal standards based on body weight and age
(23).
The transverse dimension of the left ventricular outflow
tract and the position of the mitral valve in the left ventricular
cavity were assessed at the point of mitral leaflet closure
(24,25). Mitral valve position index was calculated by di-
viding the distance between the mitral valve and posterior
left ventricular free wall endocardium by the distance be-
tween the mitral valve and ventricular septal endocardium
(24). In those patients who had not undergone cardiac cath-
eterization, the basal left ventricular outflow tract pressure
gradient was estimated based on the magnitude and duration
of systolic anterior motion of the mitral valve (26-28).
Two-dimensional echocardiography. Two-dimension-
al echocardiograms were performed with either a Varian
(V-3400 or V-3000) real time phased array 80° ultrasound
sector scanner equipped with a hand-held 2.25 MHz trans-
ducer or an ATL (Advanced Technology Laboratories, Inc.)
Mark-500 real time mechanical 90° ultrasound sector scan-
ner with 3.0 MHz transducer. Images were produced at 32
frames/s and recorded on 1 inch (2.54 ern) reel to reel
videotape using a Sony UV 340 system. These studies were
subsequently reviewed utilizing a Hitachi HR 200B system
to facilitate detailed slow motion and freeze-frame analysis.
Single still-frame photographs were made from a television
monitor with a 35 mm camera.
Assessment of distribution of left ventricular hyper-
trophy. The two-dimensional echocardiographic exami-
nation, performed to identify the distribution of left ven-
tricular hypertrophy, included the imaging of a number of
cross-sectional planes through the heart as previously de-
scribed (29,30). In the anteroposterior plane, hypertrophy
was designated as involving the ventricular septum or left
ventricular free wall, or both (3). The septum was divided
into two approximately equal segments (anterior and pos-
terior); the left ventricular free wall was divided into an-
terior, lateral and posterior segments. In the cephalad-cau-
dad plane, the left ventricle was divided into the basal portion
which extends from the cardiac base to the inferior margins
of the mitral leaflets, and the apical portion which includes
the portion of the left ventricle imaged caudal to the mitral
leaflets.
Diastolic wall thickness was measured directly from the
television monitor with the aid of calipers and a calibration
scale produced by the instrument. Thickness of the anterior
portion of the ventricular septum and posterior free wall
was also assessed quantitatively using M-mode echocardi-
ography. The anterior septum and posterior free wall were
considered to be abnormally hypertrophied if the wall was
at least 15 mm thick. For the purposes of this study, hy-
pertrophy of the posterior septum and anterolateral free wall
(as assessed with two-dimensional echocardiography in the
short-axis plane) was considered to be present if that seg-
ment was judged at two or more points to be at least 17
mm in thickness in adult patients (2::15 mm in children
younger than 16 years) (3). These criteria were selected to
ensure that (even assuming a potential lateral resolution error
of 2 to 5 mm) the frequency with which hypertrophy was
identified in these regions of the left ventricle would not be
consistently overestimated.
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Electrocardiography. Electrocardiograms were inter-
preted using criteria similar to those previously described
(31,32), In particular, left ventricular hypertrophy was di-
agnosed using the point-score system of Romhilt and Estes
(33) for patients 20 years of age or older; 5 or more points
were considered indicative of left ventricular hypertrophy,
For patients under 20 years of age, criteria derived from
studies in normal children were used (34-36); R wave or
S wave amplitude was considered abnormal if voltage s ex-
ceeded the 95% confidence limits stratified by age and sex
(36), Q or QS waves were con sidered abnormal if they were
0 .04 second or more in duration or 3 mm or more in depth
in two adjacent leads.
Statistical analysis. When appropriate, the unpaired
Student's t test was used to assess statistical significance ,
Values are expressed as the mean ± SD.
Results
M-mode echocardiography. Maximal (anterior) ven-
tricular septal thickness ranged from 30 to 50 mm (mean
37 ± 5) . Posterior left ventricular free wall thickness ranged
from 8 to 26 mm (mean 12 ± 3) . Septal to free wall
thickness ratios were I, I to 5.1 (mean 3,3 ± 0,9) and
exceeded 1,5 in 33 of the 34 patients (Fig. I), Ventricular
septal excursion was markedly diminished as evidenced by
substantial reduction in percent systolic thickening of the
septum (mean 7 ± 6%, range 0 to 25; normal > 30%)
(37,38).
Left ventricular transverse end-diastolic dimension ranged
from 20 to 51 mm (mean 38 ± 8) and was abnormally
small (relative to age and body weight) in 24 (71%) patients
and normal in the other 10. Enhanced left ventricular percent
fractional shortening (45 to 89%, mean 63 ± 13) was ev-
ident in 23 (68%) patients; the remaining II had normal
percent fractional shortening (30 to 40% , mean 37 ± 3) .
The trans verse left ventricular outflow tract dimension
was reduced in each patient (21 ± 5 mm , range 11 to 30;
normal > 30) (24) and the mitral valve was positioned an-
teriorly within the left ventricle (mitral valve position index
0.9 ± 0.3 , range 0.3 to 1.8; normal < 0 .3) in each patient.
The mitral valve was positioned more anteriorly in patients
with subaortic obstruction (index 1.3 ± 0.4) than in patients
without obstruction (index 0.8 ± 0.2; p < 0,001). Left
atrial transverse dimension ranged from 28 to 53 mm (mean
43 ± 7) and was increased relative to age and body weight
in 17 of the 34 patients .
Two-dimensional echocardiography. In each study pa-
tient , two-dimensional echocardiography defined an asym-
metric pattern of left ventricular hypertrophy (Fig. 2 to 4);
the anterior ventricular septum was the region of the left
ventricle showing maximal hypertrophy, with wall thickness
ranging from 35 to 52 mm (mean 39) .
The majority of patients (31 [90%] of 34) had left ven-
LV
Figure 1. M-mode echocardiograms obtained at the level of the
chordae tendineae from two patients with hypertrophic cardio-
myopathy with extreme increase in left ventricular wall thickness .
A, Asymmetric thickening of the ventricular septum (VS) (36 mm)
with respect to the posterior left ventricular free wall (PW) (I I
mm); septalJfree wall thickness ratio is 3.3. Ventricular septum
shows diminished excursion and systolic thickening. B, Apparent
concentric (symmetric) thickening of the ventricular septum (VS)
(33 mm) and posterior left ventricular free wall (PW) (30 mm);
septal/free wall thickness ratio is 1.1 . The two-dimensional echo-
cardiogram in this patient (see Fig. 3) shows that the overall pattern
of left ventricular hypertrophy is asymmetricwith the anterior free
wall (undetectable by M-mode echocardiography) thinner than other
segments of the wall. LV = left ventricle ; RV = right ventricle .
Calibration dots are 10 mm apart .
tricular wall thickening that was diffusely distributed , in-
volving substantial portions of the anterolateral left ven-
tricular free wall as well as the septum (Fig . 2); in 25 of
these 31 patients maximal anterolateral free wall thickness
was severe (that is, 20 to 30 mm). The posterior free wall
was of normal thickness in 30 of these 31 patients, including
two whose posterior free wall showed particularly conspic-
uous sparing, with an abrupt change in wall thickness at the
junction of the posterior wall with the posterior septum or
lateral free wall (Fig. 2A). In only one patient with diffuse
hypertrophy were all segments (including the posterior free
wall) of the left ventricle thickened (Fig. 3A). In this patient
the M-mode echocardiogram gave the appearance of con -
centric left ventricular hypertrophy becau se the anterior ven-
tricular septum and posterior free wall were similarly thick-
ened (septal/free wall ratio = 1.1; Fig. IB) Nevertheless,
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Figure 2. Stop frames of two-dimensional echo-
cardiograms obtained in the short-axis cross-sec-
tional plane (at end-diastole) from two patients with
hypertrophic cardiomyopathy and massive left ven-
tricular hypertrophy. Accompanying schematic dia-
grams are on the right. A, Particularly marked and
diffuse hypertrophy of the left ventricle shown at a
level below the mitral valve. Hypertrophy of the
ventricular septum (VS) is the most substantial of
any patient in the study group, forming a huge an-
terior ventricular septal mass (52 mm in thickness).
The anterolateral free wall is also thickened but to
a more modest extent (about 22 mm); of note, the
posterior free wall (PW) is virtually spared from
the hypertrophic process (also see Fig. 5). B, Hy-
pertrophy involving primarily the ventricular sep-
tum (VS) and contiguous portion of the anterior free
wall (ANT FW), shown at the mitral valve level.
The lateral (LAT FW)and posterior segments of the
free walls are of normal thickness. Calibration dots
are 10 mm apart.
the overall distribution of hypertrophy was asymmetric be-
cause the anterior free wall was considerably thinner than
the other left ventricular segments (Fig. 3A).
In the remaining three study patients, marked hypertro-
phy was confined to the ventricular septum and did not
involve the left ventricular free wall (Fig. 3B). In two of
these patients, hypertrophy was particularly localized, cre-
ating (in the short-axis view) the image of a massive "cap"
of anterior septal myocardium bulging into the right ven-
tricular cavity.
!!'+- -LAT
FW
Figure 3. Stop frames of two-dimensional
echocardiograms obtained in the short-axis
cross-sectional plane below the mitral valve
level (at end-diastole) in two patients with
hypertrophiccardiomyopathy and massive left
ventricular hypertrophy. Accompanying
schematic illustrations are on the right. A,
Anterior ventricular septum (VS) and pos-
terior left ventricular free wall are thickened
substantially but to a similar degree. The an-
terior free wall (arrows) is only mildly thick-
ened; hence, the pattern of left ventricular
hypertrophy is asymmetric although the path
of the M-mode beam through the anterior
ventricular septum and posterior free wall
shows concentric left ventricular hypertrophy
(see Fig. I B). B, Left ventricular wall thick-
ening is confined largely to the anterior ven-
tricular septum, whereas the anterolateral and
posterior (PW) free walls are of normal thick-
ness. Calibration dots are 10 mm apart. LAT
FW := lateral free wall.
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When the distribution of ventricular septal hypertrophy
was viewed in the cephalad-caudad long-axis plane, most
patients (28 of 34) showed the magnitude of septal thick-
ening to be relatively equal in the apical and basal portions
of the ventricle. This morphologic pattern gave the septum
the apperance of a "lemon drop," bulging equally into both
the left and right ventricular outflow tracts (Fig. 4A). By
contrast, in the other six patients (each with nonobstructive
hypertrophic cardiomyopathy) the apical portion of the sep-
tum was substantially thicker than the basal portion (Fig.
4B) (25), and the left ventricular outflow tract appeared
widened and of approximately normal size.
Chest radiographs. Mean cardiothoracic ratio in the
posteroanterior projection ranged from 0.40 to 0.65 (mean
0.52 ± 0.06). In 18 (53%) of the 34 patients the cardio-
thoracic ratio exceeded 0.50. These patients with an en-
larged cardiac silhouette did not differ from those having
normal heart size with respect to echocardiographically de-
termined left ventricular end-diastolic dimension (38 ± 8
mm versus 37 ± 8 mm) or maximal ventricular septal
thickness (37 ± 5 mm versus 38 ± 6 mm) However, left
atrial size was greater in patients with an increased cardi-
othoracic ratio (45 ± 6 mm) than in patients with a normal
cardiothoracic ratio (40 ± 7 mm; p < 0.05).
Electrocardiography. A distinctly abnormal electro-
cardiographic pattern was present in 32 of the 34 patients.
A wide variety of alterations was observed, but no single
pattern was characteristic of the overall group (Table 1).
The most common abnormalities observed were left ven-
Figure 4. Stop frames of two-dimensional echocardiograms ob-
tained in the parasternal long-axis plane (at end-diastole). Accom-
panyingschematic illustrations areon theright. Thesetwopatients
with hypertrophic cardiomyopathy and massive left ventricular
hypertrophy illustrate the variations in distribution of ventricular
septal hypertrophy in the basal to apical cross-sectional plane. A,
Massive hypertrophy of the ventricular septum (VS) with similar
magnitude of wall thickening in the basal and apical segments,
resulting in the appearance of a "lemon drop" protruding into
bothventricles (alsoseeFig. 2A). The leftventricular (LV)outflow
tract appears narrowed. B, Septal thickening is most substantial
distal to the mitral valve (MV) and the basal septumis less mark-
edly thickened. The left ventricular (LV) outflow tract appears
normal in size and the septum does not bulge into the outflow
tract. Ao = aorta; LA = left atrium; PW = posteriorfree wall.
Calibration dots are 10 mm apart.
tricular hypertrophy (26 patients) and ST segment and T
wave changes (25 patients). Conduction abnormalities were
relatively common in the study group (12 patients [35%]),
including two patients with complete heart block. Of note,
abnormal Q waves were uncommon and were identified in
only five patients.
Despite the striking increase in left ventricular mass dem-
onstrated by echocardiography in each study patient, the
magnitude of precordial and limb lead voltages was not
particularly marked (Fig. 5). QRS voltages were normal in
8 of the 34 patients; in 31 patients (excluding the 3 with
complete heart block or left bundle branch block) the S
wave in lead VI or V2 was 27 ± 15 mm, the R wave in
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26
19
7
25
17
8
17
4
5
8
12
5
2
No. of Patients
Electrocardiographic
Abnormality
Left ventricular hypertrophy
Without " strain"
With "strain"
ST-T wave abnormalities
With T wave inversion
Without T wave inversion
P wave abnormalities
Left atrial enlargement
Right atrial enlargement
Biatrial enlargement
Conduction abnonnalities*
Q waves
Normal electrocardiogram
Table 1. Electrocardiographic Findings in 34
Patients With Hypertrophic Cardiomyopathy and
Massive Left Ventricular Hypertrophy
*Includes complete heart block (two patients), left
bundle branch block (one patient), right bundle branch
block (one patient), incomplete right bundle branch block
(one patient). left anterior hemiblock (six patients) and
first degree atrioventricular block (one patient).
II III aVR aVL aVF
-r--lT
VI V: VI V. VI V,
---y'-
\I (1/ 11 )
Figure 5. Echocardiogram and electrocardiogramfrom an asymp-
tomatic 17 year old boy who demonstrated the most marked ven-
tricular septal thickening of any study patient (also see Fig. 2A
and 4A). Above, M-modeechocardiogramobtained at a leveldistal
to the mitral valve showing a markedly thickened ventricular sep-
tum (VS) (50 mm); the posterior left ventricular free wall (PW)
is of normal thickness (12 mm). Below, Scalar electrocardiogram
showing prominent QS waves in leads II, III and aVF. Precordial
QRS voltages are normal (recorded at one-half standard voltage
calibration) despite the remarkable degree of ventricular septal
thickening demonstrated by the echocardiogram. LV = left ven-
tricle; RV = right ventricle. Calibration dots are 10 mm apart.
graphic assessments of the basal subaortic gradient , 10 study
patients demonstrated obstruction to left ventricular outflow
and the other 24 patients showed no obstruction .
Left ventricular end-diastolic pressure was elevated in
12 of the 24 patients who underwent cardiac catheterization
(range 16 to 30 mm Hg , average 20) and was normal in 12
(range 4 to 14 mm Hg , average 10).
Clinical findings and natural history. Thirty of the 34
patients have a longitudinal follow-up of at least I year after
thei r init ial evaluation (max imum 19 years. mean 6). Their
symptomatic state at the initial and most recent evaluations
and changes in functional class are summarized in Figure
Figure 6. New York Heart Association functional class at initial
and most recent evaluations in 30 patients with hypertrophic car-
diomyopathy and massive left ventricular hypertrophy. VF = ven-
tricular fibrillation (with subsequent successful resuscitation).
lead Vs or V6 was 21 ± 9 mm and the R wave in lead I
or aVL was 15 ± 7 mm .
Hemodynamic characterization. Twenty-four of the 34
patients underwent cardiac catheterization. Onl y 8 of these
24 patients demonstrated a left ventricular outflow tract pres-
sure gradient under basal conditions of 30 mm Hg or greater
(range to 120 mm Hg , average 63); the other 16 had either
no basal gradient or a small gradient (10 to 25 mm Hg) . In
II of the latter 16 patients , a larger grad ient of 20 to 115
mm Hg was elicited with provocation (Valsalva maneuver,
amyl nitrite inhalation or isoproterenol infusion).
In the 10 patients who did not undergo cardi ac catheter-
ization, the basal subaortic gradient was estimated with
M-mode echocardiography. Two patients had prolonged mi-
tral-septal contact consistent with a marked basal subaortic
gradient, whereas the other eight patients showed no mitral
systolic ante rior motion, suggesting the absence of a gra-
dient. Therefore, using both hemodynamic and echocardio-
I ITIAl
EVAlUATIO
I)
III
VF
MOST REC E T
EVAl UATIO
I)
III
VF
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6. Each patient has survived during the period of follow-
up, and the proportion of patients in each functional class
did not change substantially in the overall study group during
this time.
Nine patients (30%) experienced the onset of new symp-
toms or progression of preexisting functional limitation dur-
ing the period of evaluation. One of these patients, a 32
year old man, had ventricular fibrillation while jogging and
was successfully resuscitated (over the ensuing year he has
remained asymptomatic). The other eight patients experi-
enced symptomatic deterioration by at least one functional
class despite medical therapy with a variety of drugs (pri-
marily beta-adrenergic blocking agents such as propranolol
or atenolol, or calcium channel blockers such as verapamil
or nifedipine).
Of the remaining 21 patients followed up for at least 1
year, 13 have experienced no significant change in their
symptoms or functional capacity. One of these is an II year
old boy who was identified as having hypertrophic cardio-
myopathy after an episode of ventricular fibrillation, and
who has remained asymptomatic for I year. Finally, eight
patients experienced a definite reduction in symptoms and
improvement in functional class. This improvement was
attributed to medical treatment with a variety of agents,
including verapamil (two patients), metoprolol (one pa-
tient), combinations of calcium channel or beta-blocking
drugs (three patients), disopyramide (one patient) and amio-
darone (in one patient who also underwent the ventricular
septal myotomy-myectomy operation). Of note, at the most
recent evaluation, 9 patients were asymptomatic or mini-
mally symptomatic, including 7 who remained without sig-
nificant symptoms during the entire follow-up period (6 of
the 7 were treated prophylactically with propranolol or ve-
rapamil); II other patients remained mildly symptomatic
(functional class II).
During the period of f ollow-up, patients experienced a
wide range of symptoms. The most frequent symptoms were
dyspnea and fatigue (20 patients) and presyncope (18 pa-
tients). In addition, chest pain occurred in 17, palpitation
in 14and syncope in 5. Two patients developed spontaneous
complete heart block (at ages 26 and 33 years, respectively)
necessitating demand ventricular pacing. Clinically overt
supraventricular arrhythmias resulting in symptomatic de-
terioration were identified in only one patient who had a
single episode of atrial fibrillation requiring cardioversion.
Family history analysis. Nine of the 34 study patients
have a family history of premature sudden death (at < 40
years of age) due to suspected or documented hypertrophic
cardiomyopathy; in six of these nine families a first degree
relative of the index case died suddenly. In the families of
the other 25 patients, no relatives were known to have died
prematurely, although in seven of these families hyper-
trophic cardiomyopathy had been identified clinically in a
surviving relative of the index case.
Discussion
Massively increased left ventricular wall thickness in
hypertrophic cardiomyopathy. In the present study we
have analyzed and described the findings and clinical char-
acteristics of a group of 34 patients with hypertrophic car-
diomyopathy who had striking morphologic features. Each
of these patients showed, with echocardiography, a partic-
ularly marked increase in left ventricular wall thickness
(which we arbitrarily defined as 35 mm or more). Although
other cardiac diseases associated with volume overload (for
example, aortic regurgitation) may produce considerable
increases in cardiac weight and mass that are due largely to
substantial cavity dilation (39), our patients with hyper-
trophic cardiomyopathy exhibited a marked increase in left
ventricular mass due solely to increased wall thickness in
the absence of chamber enlargement. This increase in wall
thickness exceeded in magnitude that observed in other pa-
tients with hypertrophic cardiomyopathy, as well as that
described in patients with other congenital or acquired heart
diseases (16-20) . For example, in our patients, ventricular
septal thickness averaged 39 mm and was as great as 52
mm; substantial wall thickness of 20 to 30 mm was also
present in the left ventricular free wall of about 75% of the
patients.
Clinical features. Despite similarities in magnitude and
distribution of left ventricular hypertrophy, our study pa-
tients showed marked variation in the clinical expression of
their disease. For example, less than one-third of the patients
had evidence of significant basal subaortic obstruction, al-
though each showed marked hypertrophy of the basal an-
terior septum and anterior free wall (25). Of note, the marked
and diffuse pattern of left ventricular hypertrophy that our
patients exhibited was not reflected by particularly substan-
tial increases in precordial or limb lead QRS voltages on
electrocardiography; for example, about 25% of the study
group had normal voltages and the mean value for the R
wave in the left precordial lead V 6 was only 21 mm.
Clinical course. The clinical course of the overall study
group was highly variable. Although 30% experienced a
significant deterioration in functional capacity, the remain-
ing 70% remained unchanged or improved symptomatically.
Furthermore, two-thirds of the study patients, despite their
marked morphologic expression of hypertrophic cardio-
myopathy, were asymptomatic or only mildly symptomatic
at the most recent evaluation; this included seven patients
who remained asymptomatic throughout the period of ob-
servation (almost 25% of those with follow-up). All of our
patients with massive left ventricular hypertrophy survived
over the period of observation; therefore, as a group they
showed a more favorable outcome than that previously re-
ported in large and morphologically diverse patient popu-
lations with hypertrophic cardiomyopathy (annual mortality
2 to 3%) (7,8).
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The patients in this descriptive clinical study were ana-
lyzed retrospectively and were not subjected to a systematic
drug therapy protocol. They were treated with a variety of
cardioactive drugs (primarily beta-blockers or calcium chan-
nel blockers) in a variety of dosages. Hence, it is not possible
to accurately assess whether patients with hypertrophic car-
diomyopathy and massive left ventricular hypertrophy differ
substantially from other morphologic subsets of patients
having hypertrophic cardiomyopathy with regard to the clin-
ical presentation or response to medical therapy; further-
more, we cannot be certain of the precise effect that drug
therapy had on the progression of symptoms and the prog-
nosis in our patients.
Considerations regarding selection of patients. Our
natural history data could also have been influenced by
certain potential methodologic limitations of the study de-
sign. For example, the follow-up period was relatively short
(average 6 years) and the effect of possible bias in patient
selection is unknown. We are not certain how many patients
with hypertrophic cardiomyopathy and particularly marked
left ventricular wall thickening were not referred for eval-
uation or did not appear in the present analysis because they
had already died prematurely of their cardiac disease. Fur-
thermore, the youthful age of our patients at the time of this
study (average 24 years) could also have had an influence
on the natural history findings.
We do not wish to imply that patients with hypertrophic
cardiomyopathy and massive left ventricular wall hypertro-
phy represent a distinctive and unique subgroup of the over-
all population of patients with this disease. Indeed, the dis-
tribution of left ventricular wall thickness in patients with
hypertrophic cardiomyopathy constitutes a normal curve (17),
and in this investigation we have only analyzed that small
proportion of patients at one extreme end of the distribution
curve. This approach involved establishing an arbitrary cut-
off value for left ventricular wall thickness for inclusion of
patients in the study group (that is, 35 mm or more). How-
ever, we do not suggest that patients with slightly lower
wall thickness values (but nevertheless substantial left ven-
tricular hypertrophy) are necessarily morphologically dif-
ferent from the patients in the present study group.
It should also be emphasized that the clinical course in
hypertrophic cardiomyopathy is probably multifactorially
determined. Prognosis may be importantly influenced by
genetic factors (7,9,13), the propensity to develop ventric-
ular tachycardia (40,41) and probably a number of other
variables such as impaired left ventricular diastolic function
(42-46), subaortic obstruction (6,8,47) and myocardial
ischemia (48,49). However, the reasonably favorable clin-
ical course demonstrated by many of our patients with hy-
pertrophic cardiomyopathy and massive left ventricular wall
thickness would suggest that a striking increase in left ven-
tricular mass (due to massively increased wall thickness) is
not, in itself, an absolute predictor of poor prognosis.
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